Radnostix, Inc. INIS
0.04 USD 0.00 (+0.00%)
Regular-session close
0.0341 Day range 0.0351
0.03 52-week range 0.10
- YTD
- -33.33%
- 1 year
- -33.33%
5D +0.0015 (+3.90%)
- Market cap
- 21.69M
- YTD return
- -33.33%
- 1-year return
- -33.33%
- Volume
- 82.50K
- Avg volume
- 53.32K
- Open
- 0.0351
- Previous close
- 0.04
- Day's range
- 0.0341 – 0.0351
- 52-week range
- 0.03 – 0.10
Fundamental scorecard
6 of 25 checks passed on INIS’s reported financials
6of 25 checks passed
- Value 2 of 5
- Growth 2 of 5
- Profitability 0 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Jun 30, 2023.
Financials — quick view
INIS Revenue — quarterly 3.11M
INIS Net income — quarterly -263.30K
INIS EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
Radnostix, Inc. Reports FY2026 3rd Quarter and Nine Months Results - Theranostics Sales Up 15% Year-over-Year, Signs Agreement to Sell Fluorine Products/DUF6 Assets to Nano Nuclear Energy, Submits Typ
Radnostix, Inc. Reports FY2026 3rd Quarter and Nine Months Results - Theranostics Sales Up 15% Year-over-Year, Signs Agreement to Sell Fluorine Products/DUF6 Assets to Nano Nuclear Energy, Submits Type II DMF for Sodium Iodide I-131 API
Your note
Sign in to keep a note on INIS — it syncs with the Stock Master app.
